Abstract Dentoleukoencephalopathies with autosomal recessive inheritance are very rare. Recently, a large inbred Syrian pedigree was reported with oligodontia in association with a degenerative neurologic condition characterized by progressive ataxia and pyramidal syndrome and abnormalities in the white matter and cortical atrophy. A wholegenome screening of this family using 382 microsatellite markers was completed, but no evidence was found of linkage to any chromosomal region. A genome-wide linkage analysis using the 260K single nucleotide polymorphism Affymetrix array was then undertaken and a maximum multipoint logarithm of the odds score of 5.66 (NPL score=7.65) was detected on chromosome 10q22 region. This genomic interval contains 95 known genes including the Prosaposin gene (PSAP) responsible for metachromatic leukodystrophy, which was excluded. Seventeen additional candidate genes were tested and excluded. Sequencing of the whole candidate locus is in progress and should allow the identification of the causative gene in this rare disease, thereby improving the understanding of the physiopathology of this disease.
Introduction
Leukodystrophies are hereditary disorders of the white matter, which are invariably progressive. The first clinical description of inherited white matter diseases, 100 years ago, mentioned familial occurrence, early onset spasticity, and a rapidly progressive course with fatal outcome. Histopathology studies revealed extensive demyelination in the CNS that gave rise to the term "leukodystrophy" (leuko-white, dystrophy-degenerating) [1] . Classical leukodystrophies, such as the metachromatic leukodystrophy and Krabbe disease, account for only a small number of inherited diseases, affecting the white matter, and up to the present, more than 100 other entities have been inventoried [2, 3] . Common clinical features include neurological deterioration following a period of normal development, predominant involvement of the motor function at least initially, and absence of convulsions or myoclonus [4] . Magnetic resonance imaging (MRI) shows changes in density or signal from central white matter.
In this study, we present the results of a genome-wide scan in a large inbred Syrian family that includes six patients affected with leukodystrophy associated with oligodontia [2] . The disease locus was linked to single nucleotide polymorphism (SNP) markers on 10q22, a new locus related to inherited leukodystrophies.
Materials and methods

Patients and clinical investigations
Six siblings with sub-total anodontia and neurodegenerative disease appearing at around age 12 years, with abnormalities of the white matter and cortical atrophy, as well as 13 normal sibs from a large consanguineous family were included in our study (Fig. 1 ).
Molecular studies
Isolation of genomic DNA EDTA blood samples from 19 individuals, including 6 affected individuals, were collected with informed consent for genetic studies. The study has been approved by our local ethics committee. DNA was extracted from whole blood by standard salt-precipitation methods [5] .
Genome-wide screening using short tandem repeat markers Using short tandem repeat (STR) markers, we performed homozygosity mapping for the first nuclear family including parents IV-1 and 2 and their eight children while parents V-1 and 2 and their children were not available for this part of the study (Fig. 1) . Genome-wide genotyping was accomplished with the use of the ABI Prism® Linkage Mapping Set, version 2.5 (Applied Biosystems, Foster City, CA, USA) I   II   III   IV   V   1  2  3  4  5  6  7  8   1  2  3   1  2   9  10 11 12 13 14 15  16   3 1  BA  AB  AB  AB  BA  BA  1 3  2 1   2 1  BA  AB  AB  AB  BA  AA  2 3  1 1   D10S537  rs10823772  rs4268450  rs2456251  rs11002648  rs1483733  rs927452  D10S1686  D10S185   1 2  AB  BA  BA  BA  AB  AA  3 2  1 1   D10S537  rs10823772  rs4268450  rs2456251  rs11002648  rs1483733  rs927452  D10S1686  D10S185   1 1  AA  BB  BB  BB  AA  AA  3 3  1 1   1 1  AA  BB  BB  BB  AA  AA  3 3  1 1   1 2  AA  BB  BB  BB  AA  AA  3 3  1 1   1 1  AA  BB  BB  BB  AA  AA  3 [6] . We assumed a recessive model with complete penetrance, a frequency of 0.001 for the disease allele, equally distributed marker allele frequencies, and standard recombination rates. Multipoint logarithm of the odds (LOD) scores were generated using Genehunter and haplotypes were reconstructed manually.
VI
Genome-wide screening using single nucleotide polymorphism markers
A genome-wide search was carried out, at PartnerChip (Evry, France) by using the Affymetrix GeneChip Mapping NspI chip® for 15 individuals including the 6 affected patients, their respectively parents, and 5 additional non-affected siblings. The GeneChip Mapping NspI Affymetrix array allowed genotyping of approximately 260,000 SNPs with a mean intermarker distance of 10 kb and an average heterozygosity of 0.38 (http://www.affymetrix.com). Genotyping reactions were performed according to the manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The arrays were scanned with the GeneChip Scanner 3000 7G® and the data were processed with GeneChip Operating Software (GCOS, ver. 1.4) and GeneChip Genotyping Analysis Software (GTYPE, ver. 4.1) [7] . Call rates for all genomic DNA samples were >93%, equal or above the Affymetrix recommended minimum call rate of 93%. Pairwise LOD scores were calculated with the Agilent GeneSpring GT (VARIA) software assuming an autosomal recessive model. Linkage analysis was assessed with the Caucasian allele frequencies provided by Affymetrix.
Screening of candidate genes
Entire coding regions as well as intron-exon boundaries of a total of 17 genes were amplified by PCR and analyzed for identification of sequence variants. For this purpose, intronic primers were designed for each exon using the Primer3 software [8] and OLIGOS v.9.3 and checked for specificity using BLAST (http://www.ncbi.nlm.nih.gov/ blast). DNA sequences were obtained from UCSC Human Genome browser (http://www.genome.ucsc.edu). Amplification was carried out in a total volume of 50 μl with 100 ng of genomic DNA, 0.5 μM of each primer, 250 μM of each dNTP, 1.5 mM of MgCl 2 , 10 mM Tris-HCl (pH 8.3), 50 mM of KCl, and 1 U of Taq DNA polymerase (Invitrogen Life Technologies, Carlsbad, CA, USA). Amplified DNA fragments were purified using the Ultra PCR Clean-Up Kit (ABgene, Surrey, UK), and both strands of the resultant products were sequenced using the BigDye® Terminator Cycle Sequencing Kits v1.1 or v3.1 (Applied Biosystems) under standard conditions. After removal of unincorporated dyes by purification on Sephadex G50 (Amersham Pharmacia Biotech, Foster City, CA, USA), the labeled products were dissolved in HiDi formamide and subjected to denaturing electrophoresis loaded on an ABI 310 Genetic Analyzer sequencing system (Applied Biosystems). Electropherograms were analyzed using Sequence Analysis Software version 3.4.1 (Applied Biosystems) and compared to reference sequences using ChromasPro version 1.22 (Technelysium, Queensland, Australia). Any DNA variants identified in an affected individual were subsequently screened by sequencing in all family members.
Results
Clinical findings
The family studied here consists of 19 members with 6 individuals presenting leukodystrophy associated with oligodontia. Clinical features had been described previously for affected individuals VI-2, VI-5, VI-6, and VI-7 [2] . Briefly, all patients presented with sub-total anodontia, signs of abnormal gait appearing at around age 12 years, dysarthria, brisk tendinous reflexes, diminished vibratory sense, diminished positional sense, diminished muscle strength, intentional tremor, and enophtalmia. MRIs revealed degeneration of the deep white matter of the centrum semi-ovale in both hemispheres. In the advances cases, this degeneration extended to the temporal-occipital white matter bilaterally. Cortical brain atrophy was noticed on all patients. All patients had normal laboratory test results. A second branch of the family was identified afterwards, and both affected individuals (patients VI.11 and VI.12) share the same clinical signs than their cousins (Table 1) .
Molecular findings
The genome-wide screening using STR markers performed in the first nuclear family enabled the identification of two STR markers homozygous by descent: (1) the first one D8S285 (AFM255yb9) on chromosome 8p12-q12.2 between markers D8S505 (AFM198tb2) and D8S260 (AFM114xe7) covering a 27-Mb region, and (2) the second one D10S1686 (AFM191va9) on chromosome 10q22.1-q23.33 between markers D10S537 (AFM203xc5) and D10S185 (AFM019th6) covering a 23-Mb region.
In order to determine which one of these two loci was a candidate region for containing the disease gene, members from the second nuclear family were genotyped at the two STR markers D8S285 and D10S1686; however, no linkage was detected (Fig. 1) for both STR markers. A genomewide linkage analysis was then undertaken of the 15 individuals including the 6 affected patients, their parents, and 5 non-affected siblings, using the GeneChip Mapping NspI containing 260,000 SNPs with a mean intermarker distance of 10 kb. A maximum multipoint LOD score value of 5.66 (NPL score=7.65) was obtained at a locus on chromosome 10q22 (Fig. 2) (Table 2 ) was searched for DNA variants. Unfortunately, no causative mutation was identified in any of these genes.
Discussion
Patients from the family reported herein are affected with an autosomal recessive leukodystrophy associated with oligodontia. Since our first description in 2003, several Adaptor-related protein complex 3 mu (it facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes) NM_207012 9 NM_012095
C10ORF55
Hypothetical protein
DUPD1
Dual specificity phosphatase and pro-isomerase (belongs to the protein-tyrosine phosphatase family) NM_001003892 3
NDST2
Bifunctional heparan sulfate (it has dual functions in processing glucosamine and heparin polymers) NM_003635 15
SAMD8
Sphingomyelin synthase-related protein (its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, yielding diacylglycerol)
NM_144660 5 NM_001174156
ADK
Adenosine kinase (it catalyzes the transfer of the gamma-phosphate from ATP to adenosine)
Calcium-activated potassium channel subunit (it is fundamental to the control of smooth muscle tone and neuronal excitability)
Voltage-dependent anion-selective channel (it is a member of proteins that are considered the main pathway for metabolite diffusion across the mitochondrial outer membrane) NM_003375 10 NM_001184823 NM_001184783
ZNF503
Zinc finger protein 503 (may function as a transcriptional repressor)
Urokinase-type plasminogen activator (involved in degradation of the extracellular matrix)
Chondroitin 6-sulfotransferase 3 (it catalyzes the sulfation of chondroitin, found in most cells and involved in cell migration and differentiation) NM_004273 4
DUSP13
Dual specificity protein phosphatase 13 (may be involved in postnatal development of specific tissues) NM_001007272 17 NM_001007273 NM_016364 NM_001007271
PLA2G12B
Phospholipase A2, group XIIB precursor (may catalyze hydrolysis of glycolipids) NM_032562 5 other families have been described with members presenting overlaping clinical signs [9, 10] . First, four unrelated German or Swiss girls presented early onset of progressive ataxia during the second year of life, mild to moderate brain hypomyelination, cerebellar atrophy, and delayed dentition [9] . The first teeth to appear were the deciduous molars. Some patients were missing permanent teeth. All patients also had short stature. The disorder was distinguished clinically from the phenotype reported by us in 2003 [9] . Moreover, in 2006, Timmons et al. reported four unrelated patients with delayed tooth eruption and hypodontia of permanent teeth [10] . Three patients were otherwise normal until age 12 years, when progressive hypomyelination and dysmyelination resulted in ataxia, dysmetria, spasticity, dysarthria, and extensor plantar responses. The fourth patient had onset at age 7. None of the patients had spontaneous puberty due to hypogonadotropic hypogonadism. They also presented cognitive deficits. Sural nerve biopsy showed granular debris-lined clefts, expanded abaxonal space, vacuolar disruption, and loss of normal myelin periodicity. Brain MRI revealed central hypomyelination and cerebellar atrophy. Timmons et al. proposed the designation "4H syndrome" [10] . In comparison to the Syrian family described by us in 2003, the Syrian patients do not present any hypogonadotropic hypogonadism. The genetic loci for the families described by Wolf et al. and Timmons et al. are still undefined. In our Syrian family [2] , the first attempt of linkage using 382 STR conducted showed no evidence of linkage to any chromosomal region. This finding is most probably related to the multigenerational pedigree of the family. Indeed, while the disease allele is transmitted through generations, the region on either side of the gene that remains identical by descent will decrease in size because of crossing-overs. When the spacing between markers is too wide, 10-20 cM in our case, the probability of missing the true location of the disease gene increases. Thus, a genome-wide linkage analysis using SNP arrays was performed and enabled us to detect a 8.7-Mb candidate region on chromosome 10q22 with a maximum multipoint LOD score of 5.66. Despite the poor informativity of SNP markers, this method proved to be more powerful than the standard STR genome-wide screening at 10 cM spacing, and this is due to the high density of markers. This might be particularly true in large consanguineous families, where consanguinity often leads to a loss of informativity of STR markers. However, a higher density of SNPs is required in order to compensate for non-informative markers.
Of the 95 genes lying in the identified candidate region, several were excellent candidates for the disease and were initially screened for sequence variations. Consequently, the Prosaposin gene (PSAP) responsible for metachromatic leukodystrophy was the first gene to be excluded. Genes that are expressed in the brain, the nervous system, or implicated in tooth development were then selected and screened for mutations. The entire coding regions as well as intron-exon boundaries of a total of 16 additional genes (Table 2) were studied. Unfortunately, no pathogenic mutation was identified in any of these genes. However, as only exons and splice junction sites of the 17 genes were sequenced, the possibility that a pathogenic variant might lie in the regulatory regions or in distant intronic regions of these genes cannot be ruled out.
Seventy-seven other known genes and several expressed sequenced tags are also present in the candidate interval. Thus, further fine-mapping by recruiting additional families as well as sequencing work is in process in order to identify the mutant gene, which causes this autosomal recessive form of dentoleukoencephalopathy in the family presented here. Identification of the gene involved in this disease will improve the understanding of the physiopathology of this disorder, which seems not to be as rare as it was thought.
